SYRS Financials
Syros Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$0.00
Market Cap
$9,391
Income Statement Highlights
Most Recent Quarter: 2023-12-31
Revenue
$9.94M
Gross Profit
-
Operating Income
-
Net Income
$-164.57M
EPS (Diluted)
$-5.81
Balance Sheet Highlights
Total Assets
$168.17M
Total Liabilities
-
Shareholders Equity
-
Cash & Equivalents
$139.53M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-109.71M
CapEx
-
Free Cash Flow
-
Profitability Metrics
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is SYRS revenue?
SYRS's most recent quarterly revenue was $9.94M. Annual revenue can be calculated by summing the four most recent quarters.
Is SYRS profitable?
SYRS reported a loss of $164.57M in the most recent quarter.
What is SYRS market cap?
SYRS has a market capitalization of $9,391, making it a small-cap stock.
Does SYRS have debt?
View SYRS's balance sheet for debt information.
What is SYRS cash flow?
Cash flow data is available in the full financial statements.